These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24504678)

  • 1. Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis.
    Wu Y; Yang Y
    Tumour Biol; 2014 Jun; 35(6):5245-57. PubMed ID: 24504678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.
    Li SX; Dai QS; Chen SX; Zhang SD; Liao XY; Deng X; Chi HB; Li FJ; Zhu JH; Jiang YY
    Tumour Biol; 2014 Apr; 35(4):3905-15. PubMed ID: 24347488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive assessment of associations between ERCC2 Lys751Gln/Asp312Asn polymorphisms and risk of non- Hodgkin lymphoma.
    Zhou JY; He LW; Liu J; Yu HL; Wei M; Ma WL; Shi R
    Asian Pac J Cancer Prev; 2014; 15(21):9347-53. PubMed ID: 25422223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XPD polymorphisms, cigarette smoking, and bladder cancer risk: a meta-analysis.
    Wang M; Gu D; Zhang Z; Zhou J; Zhang Z
    J Toxicol Environ Health A; 2009; 72(11-12):698-705. PubMed ID: 19492231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
    Xiao F; Pu J; Wen Q; Huang Q; Zhang Q; Huang B; Huang S; Lan A; Zhang Y; Li J; Zhao D; Shen J; Wu H; He Y; Li H; Yang X
    Oncotarget; 2017 Jul; 8(29):48488-48506. PubMed ID: 28489582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
    Zhang Y; Ding D; Wang X; Zhu Z; Huang M; He X
    Int J Colorectal Dis; 2011 Oct; 26(10):1257-64. PubMed ID: 21541661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
    Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
    World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India.
    Gangawar R; Ahirwar D; Mandhani A; Mittal RD
    Med Oncol; 2010 Jun; 27(2):159-66. PubMed ID: 19242824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.
    Yin QH; Liu C; Hu JB; Meng RR; Li L; Wang YJ
    Asian Pac J Cancer Prev; 2013; 14(1):231-6. PubMed ID: 23534729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
    Feki-Tounsi M; Khlifi R; Louati I; Fourati M; Mhiri MN; Hamza-Chaffai A; Rebai A
    Environ Sci Pollut Res Int; 2017 Oct; 24(28):22476-22484. PubMed ID: 28803404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis.
    Chen B; Zhou Y; Yang P; Wu XT
    J Cancer Res Clin Oncol; 2011 Jun; 137(6):939-46. PubMed ID: 20981556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
    Ma Q; Qi C; Tie C; Guo Z
    Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.
    Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Res; 2002 Mar; 62(5):1377-81. PubMed ID: 11888908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.
    Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
    Medicine (Baltimore); 2014 Dec; 93(29):e330. PubMed ID: 25546681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population.
    Yin J; Vogel U; Ma Y; Qi R; Sun Z; Wang H
    Cancer Genet Cytogenet; 2007 May; 175(1):47-51. PubMed ID: 17498557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis.
    Li C; Jiang Z; Liu X
    Mol Biol Rep; 2010 Jan; 37(1):301-9. PubMed ID: 19669592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.
    Xue H; Lu Y; Lin B; Chen J; Tang F; Huang G
    PLoS One; 2012; 7(9):e43431. PubMed ID: 23028453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility.
    Wen F; Zhao Z; Liu C; Yin Q; Weng J; Wang Y; Ma Y
    Tumour Biol; 2014 Apr; 35(4):2959-65. PubMed ID: 24234258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk.
    Schabath MB; Delclos GL; Grossman HB; Wang Y; Lerner SP; Chamberlain RM; Spitz MR; Wu X
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):878-84. PubMed ID: 15824159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.
    Zhu H; Cao S; Liu Y; Ding X; Wu Q; Ma H
    J Cancer Res Ther; 2013; 9(2):187-92. PubMed ID: 23771356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.